4Bio Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Ray TherapeuticsMay 2023SEC filingmedium confidence
Restoring vision through optogenetics.
BiotechSan Francisco, US
Paul Bresge(Executive Officer, Director)Sean Ainsworth(Executive Officer, Director)
BoardTiba Aynechi(Director)inRaymond Camahort(Director)Hannah Chang(Director)
Board seatDmitry Kuzmin· per SEC Form D · $100M raise · filed May 2023
Co-investorsMRL Ventures FundNorwest Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.